| Health / Medical Topics |
PSA RNA-Pulsed Dendritic Cell Vaccine
An autologous dendritic cell vaccine with potential immunostimulatory activity. Dendritic cells harvested from a prostate cancer patient are transfected with the mRNA encoding for prostate specific antigen (PSA), a tumor marker secreted by prostatic epithelial and ductal cells. When reintroduced back to the patient, these PSA RNA pulsed autologous dendritic cells may elicit a cytotoxic T-cell (CTL) response against PSA-positive prostate cancer cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
A peptide vaccine containing the prostate specific antigen (PSA) with potential antineoplastic activity. PSA, a glycoprotein secreted by prostatic epithelial and ductal…
A rise in the blood level of PSA (prostate-specific antigen) in prostate cancer patients after treatment with surgery or radiation. PSA failure…
A brief rise and then fall in the blood level of PSA (prostate-specific antigen) that occurs in some patients 1-3 years after…
Any immunoglobulin that recognizes prostate-specific antigen.
A protein made by the prostate gland and found in the blood. PSA blood levels may be higher than normal in men…
A drug used to treat multiple myeloma. It is also used to treat mantle cell lymphoma in patients who have already received…
